TERT and hepatocellular carcinoma: In 10–15% of HCC cases there is an upregulation of oncogenes of the enhancer II/core HBV promoter in/near telomerase reverse transcriptase (TERT) or myeloid/lymphoid or mixed-lineage leukemia 4 genes caused by a recurrent integration of dslDNA [42,43].